Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06744543 · ClinicalTrials.gov registry record · NA
Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease
A NA study of Genetic Disease and Pediatrics, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT06744543: Active NA study of Genetic Disease and Pediatrics, sponsored by Vanderbilt University Medical Center.
NCT06744543 is a NA study of Genetic Disease and Pediatrics that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 1,000 participants, below the 2,528-participant average among 30 other Genetic Disease trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06744543, a NA study of Genetic Disease and Pediatrics, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of SIGHT as a clinical support system to prompt provider/patient discussion and shared decision making regarding the need for genetic testing in the form of a chromosomal microarray. Identifying patients at high predicted probability of needing a test in clinical settings will be examined to determine if it decreases the duration of time to testing and increases diagnostic yield. SIGHT requires only data already collected in routine clinical encounters and is calculated prior to a clinical visit at VUMC.
Primary Outcome
Number of patients diagnosed via a Chromosomal Microarray.
Conditions Studied
Interventions
- DEVICE SIGHT Prompted Provider Message
Study Locations (1)
Tennessee
- Vanderbilt University Medical - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-03-12 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
What the registry record for NCT06744543 still lists
NCT06744543 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 2,528-participant average among 30 other Genetic Disease trials with a reported enrollment target (60% lower).
The record links to 4 conditions, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which SIGHT Prompted Provider Message is the first listed.
NCT06744543 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06744543 about?
NCT06744543 is a clinical study titled "Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease". This study will evaluate the effectiveness of SIGHT as a clinical support system to prompt provider/patient discussion and shared decision making regarding the need for genetic testing in the form of a chromosomal microarray. Identifying patients at high predicted probability of needing a test in cl...
What is the current status of trial NCT06744543?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-03-12. Estimated completion is 2027-02-01.
What conditions does trial NCT06744543 study?
This clinical trial studies the following conditions: Genetic Disease, Pediatrics, Clinical Decision Support, Predictive Model.
What interventions are being tested in trial NCT06744543?
The interventions under investigation include: SIGHT Prompted Provider Message (DEVICE).
Who is sponsoring clinical trial NCT06744543?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06744543 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06744543's enrollment target sits among peer trials
1,000 6th of 30 higher than 24 of 30 other Genetic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Genetic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Large Language Models To Improve the Quality of Care of Cardiology Patients
RECRUITING · NA
-
Grand Valley State University (GVSU) Skills on Wheels
ACTIVE NOT RECRUITING · NA
-
Overcoming Barriers to Accessing Genetic Medicine
ACTIVE NOT RECRUITING · NA
-
Pediatric Powered Wheelchair Standing Devices: An Exploratory Study
ACTIVE NOT RECRUITING · NA
-
The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI